Your browser doesn't support javascript.
loading
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.
Ferreira, Manuel A; Gamazon, Eric R; Al-Ejeh, Fares; Aittomäki, Kristiina; Andrulis, Irene L; Anton-Culver, Hoda; Arason, Adalgeir; Arndt, Volker; Aronson, Kristan J; Arun, Banu K; Asseryanis, Ella; Azzollini, Jacopo; Balmaña, Judith; Barnes, Daniel R; Barrowdale, Daniel; Beckmann, Matthias W; Behrens, Sabine; Benitez, Javier; Bermisheva, Marina; Bialkowska, Katarzyna; Blomqvist, Carl; Bogdanova, Natalia V; Bojesen, Stig E; Bolla, Manjeet K; Borg, Ake; Brauch, Hiltrud; Brenner, Hermann; Broeks, Annegien; Burwinkel, Barbara; Caldés, Trinidad; Caligo, Maria A; Campa, Daniele; Campbell, Ian; Canzian, Federico; Carter, Jonathan; Carter, Brian D; Castelao, Jose E; Chang-Claude, Jenny; Chanock, Stephen J; Christiansen, Hans; Chung, Wendy K; Claes, Kathleen B M; Clarke, Christine L; Couch, Fergus J; Cox, Angela; Cross, Simon S; Czene, Kamila; Daly, Mary B; de la Hoya, Miguel; Dennis, Joe.
Afiliação
  • Ferreira MA; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia. Manuel.Ferreira@qimr.edu.au.
  • Gamazon ER; Division of Genetic Medicine, Department of Medicine, Vanderbilt University, Nashville, TN, 37235, USA.
  • Al-Ejeh F; Clare Hall, University of Cambridge, Cambridge, CB3 9AL, UK.
  • Aittomäki K; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
  • Andrulis IL; Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, 00290, Helsinki, Finland.
  • Anton-Culver H; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada.
  • Arason A; Department of Molecular Genetics, University of Toronto, Toronto, ON, M5S 1A8, Canada.
  • Arndt V; Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA, USA, 92617.
  • Aronson KJ; Department of Pathology, Landspitali University Hospital, 101, Reykjavik, Iceland.
  • Arun BK; BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, 101, Reykjavik, Iceland.
  • Asseryanis E; Division of Clinical Epidemiology and Aging Research, C070, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Azzollini J; Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, ON, K7L 3N6, Canada.
  • Balmaña J; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Barnes DR; Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria.
  • Barrowdale D; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133, Milan, Italy.
  • Beckmann MW; Oncogenetics Group, Vall dHebron Institute of Oncology (VHIO), 8035, Barcelona, Spain.
  • Behrens S; Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), University Hospital, Vall d'Hebron, 08035, Barcelona, Spain.
  • Benitez J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
  • Bermisheva M; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
  • Bialkowska K; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, 91054, Erlangen, Germany.
  • Blomqvist C; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Bogdanova NV; Centro de Investigación en Red de Enfermedades Raras (CIBERER), 46010, Valencia, Spain.
  • Bojesen SE; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.
  • Bolla MK; Institute of Biochemistry and Genetics, Ufa Federal Research Centre of Russian Academy of Sciences, 450054, Ufa, Russia.
  • Borg A; Department of Genetics and Pathology, Pomeranian Medical University, 71-252, Szczecin, Poland.
  • Brauch H; Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, 00290, Finland.
  • Brenner H; Department of Oncology, Örebro University Hospital, 70185, Örebro, Sweden.
  • Broeks A; Department of Radiation Oncology, Hannover Medical School, 30625, Hannover, Germany.
  • Burwinkel B; Gynaecology Research Unit, Hannover Medical School, 30625, Hannover, Germany.
  • Caldés T; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, 223040, Minsk, Belarus.
  • Caligo MA; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730, Herlev, Denmark.
  • Campa D; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730, Herlev, Denmark.
  • Campbell I; Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark.
  • Canzian F; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
  • Carter J; Department of Oncology, Lund University and Skåne University Hospital, 222 41, Lund, Sweden.
  • Carter BD; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376, Stuttgart, Germany.
  • Castelao JE; University of Tübingen, 72074, Tübingen, Germany.
  • Chang-Claude J; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Chanock SJ; Division of Clinical Epidemiology and Aging Research, C070, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Christiansen H; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Chung WK; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120, Heidelberg, Germany.
  • Claes KBM; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, 1066 CX, Amsterdam, The Netherlands.
  • Clarke CL; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Couch FJ; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Cox A; Department of Biology, University of Pisa, 56126, Pisa, Italy.
  • Cross SS; Research Department, Peter MacCallum Cancer Center, Melbourne, VIC, 3000, Australia.
  • Czene K; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, 3000, Australia.
  • Daly MB; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • de la Hoya M; Department of Gynaecological Oncology, Chris O'Brien Lifehouse and The University of Sydney, Camperdown, NSW, 2050, Australia.
  • Dennis J; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA, 30303.
Nat Commun ; 10(1): 1741, 2019 04 15.
Article em En | MEDLINE | ID: mdl-30988301

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Predisposição Genética para Doença Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Predisposição Genética para Doença Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido